Zhejiang Chimin Pharm Co Ltd Total Liabilities
Zhejiang Chimin Pharm Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) has total liabilities worth CN¥1.04 Billion CNY (≈ $151.79 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang Chimin Pharm Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Chimin Pharm Co Ltd (2011–2025)
Total liabilities of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025. This chart illustrates how Zhejiang Chimin Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 603222 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Zhejiang Chimin Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Chimin Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningbo Shenglong Automotive Powertrain System Co Ltd
SHG:603178
|
China | CN¥959.67 Million |
|
Mediterranean Towers Ltd
TA:MDTR
|
Israel | ILA5.15 Billion |
|
Basler Kantonalbank
SW:BSKP
|
Switzerland | CHF51.12 Billion |
|
Ningbo Marine Co Ltd
SHG:600798
|
China | CN¥1.88 Billion |
|
Guangzhou Jinyi Media Corp
SHE:002905
|
China | CN¥2.19 Billion |
|
ROX Resources Ltd
AU:RXL
|
Australia | AU$12.10 Million |
|
Sage Therapeutics Inc
NASDAQ:SAGE
|
USA | $54.19 Million |
|
Ningbo Fangzheng Automobile Mould Co.Ltd.
SHE:300998
|
China | CN¥1.11 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Zhejiang Chimin Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603222 asset base.
Liquidity & Leverage Metrics
Zhejiang Chimin Pharm Co Ltd Total Liabilities Ratios Explained
Zhejiang Chimin Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Chimin Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Chimin Pharm Co Ltd (2011–2025)
The table below shows the annual total liabilities of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.00 Billion ≈ $146.93 Million |
+18.66% |
| 2024-12-31 | CN¥846.22 Million ≈ $123.83 Million |
+3.18% |
| 2023-12-31 | CN¥820.13 Million ≈ $120.01 Million |
-12.72% |
| 2022-12-31 | CN¥939.64 Million ≈ $137.50 Million |
-10.55% |
| 2021-12-31 | CN¥1.05 Billion ≈ $153.72 Million |
-15.67% |
| 2020-12-31 | CN¥1.25 Billion ≈ $182.29 Million |
+23.13% |
| 2019-12-31 | CN¥1.01 Billion ≈ $148.04 Million |
-6.17% |
| 2018-12-31 | CN¥1.08 Billion ≈ $157.78 Million |
+66.75% |
| 2017-12-31 | CN¥646.63 Million ≈ $94.62 Million |
+469.79% |
| 2016-12-31 | CN¥113.49 Million ≈ $16.61 Million |
+22.00% |
| 2015-12-31 | CN¥93.02 Million ≈ $13.61 Million |
-50.65% |
| 2014-12-31 | CN¥188.49 Million ≈ $27.58 Million |
-16.32% |
| 2013-12-31 | CN¥225.24 Million ≈ $32.96 Million |
-12.73% |
| 2012-12-31 | CN¥258.10 Million ≈ $37.77 Million |
-5.20% |
| 2011-12-31 | CN¥272.26 Million ≈ $39.84 Million |
-- |
About Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture m… Read more